From: Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer
Inevaluable core biopsies
Single core biopsies
Double core biopsies
CVbetween
CVwithin
FAK
4
18
98
12.8%
6.4%
pFAK
12
29
79
17.4%
9.8%
Src
16
100
16.9%
7.4%
pSrc
5
97
14.1%
6.3%